Second Genome
  • About
    • About Us
    • Our Team
  • Pipeline
    • Pipeline
    • SG-5-00455
    • SG-3-06686
  • Platform
    • Platform
    • Drug Delivery System
    • Publications
    • Posters
  • News
    • News
    • Events
  • Careers
  • Contact

Talk

Lightweight Multi-Tenancy with Django Guardian

October 15, 2021

READ MORE

Helios2(Neo4j) for Discovering Drugs and Biomarkers

August 16, 2021

READ MORE

Discovery of Pharmacological Agents Emitted by Intestinal Bacteria

January 20, 2021

READ MORE

Microbiome-based biomarker predicts response to immune checkpoint inhibitor therapy in a melanoma meta-cohort independently of clinical features

January 10, 2021

READ MORE

Multi-technology Meta-analysis Identifies Bacterial Signatures Delineating Clinical Response to Immune Checkpoint-Inhibitor Therapy in Melanoma Cohorts

November 9, 2019

READ MORE

Targeting the Inflammasome through P2X7 receptor, and its Potential Implications for NASH Therapy

October 21, 2019

READ MORE

Leveraging Second Genome’s platform to develop microbiome-derived cancer immunotherapy

July 15, 2019

READ MORE

Targeting the inflammasome through P2X7, a Purinergic Receptor Antagonist

December 25, 2018

READ MORE

Second Genome
  • About
  • Pipeline
  • Platform
  • News
  • Careers
  • Contact

Copyright © 2023 All rights reserved.